Clinical Trials in Osteosarcoma
1. Therapeutic trials
Newly Diagnosed Osteosarcoma
Phase III
- A Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies for Resectable Osteosarcoma Based on Histological Response to Pre-Operative Chemotherapy. Read More >
Phase II
- Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma. Read More >
- Neoadjuvant and Adjuvant Pamidronate With Induction and Maintenance Chemotherapy in Treating Patients With Osteosarcoma. Read More >
- Bone Cancer: Treatment Outcome Based on Tumor Response. Read More >
Relapsed Osteosarcoma (Lung)
Phase II
- Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma. Read More >
Phase Ib/IIa
- Inhalation SLIT Cisplatin for the Treatment of Osteosarcoma Metastatic to the Lung. Read More >
Recurrent, refractory Osteosarcoma
Phase II
- Samarium Sm 153 Lexidronam Pentasodium and Autologous Stem Cell Transplant Followed By Radiation Therapy in Treating Patients With Recurrent or Refractory, Metastatic, or Unresectable Osteosarcoma. Read More >
Phase I
- Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent Osteosarcoma. Read More >
2. Non-Therapeutic trials
- Osteosarcoma Biology Protocol: Companion to Children's Oncology Group Therapeutic studies. Read More >
- Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma. Read More >
Osteosarcoma Online > Health Professionals > Clinical Trials in Osteosarcoma
Site Design: Caroline Courtney